Your browser doesn't support javascript.
loading
HEPATIC DYSFUNCTION IN MEDICAL INTENSIVE CAREUNIT PATIENTS PREDICTS POOR OUTCOME.
Patel, Sameet T; Rajadhyaksha, Girish C; Junare, Parmeshwar; Contractor, Qais Q; Souza, Rosemarie de; Rathi, Pravin M.
Afiliação
  • Patel ST; Department of Gastroenterology, T.N.M.C and B.Y.L Nair Ch. Hospital, Mumbai, India.
  • Rajadhyaksha GC; Department of General Medicine, T.N.M.C and B.Y.L Nair Ch. Hospital, Mumbai, India.
  • Junare P; Department of Gastroenterology, T.N.M.C and B.Y.L Nair Ch. Hospital, Mumbai, India.
  • Contractor QQ; Department of Gastroenterology, T.N.M.C and B.Y.L Nair Ch. Hospital, Mumbai, India.
  • Souza R; Department of General Medicine, T.N.M.C and B.Y.L Nair Ch. Hospital, Mumbai, India.
  • Rathi PM; Department of Gastroenterology, T.N.M.C and B.Y.L Nair Ch. Hospital, Mumbai, India.
Arq Gastroenterol ; 59(2): 164-169, 2022.
Article em En | MEDLINE | ID: mdl-35830023
ABSTRACT

BACKGROUND:

A large number of patients admitted to the medical intensive care unit (MICU) have abnormal liver function tests (LFT). This includes patients with critical illness with or without preexisting liver disease and patients with acute primary liver injury. There are very few studies which have investigated the spectrum of liver disease, clinical profile and outcome in patients admitted to the MICU.

OBJECTIVE:

To evaluate the occurrence, etiology, clinical profile, laboratory profile and outcome of hepatic dysfunction in patients admitted to the MICU. To evaluate the utility of model for end-stage liver disease (MELD) score on admission as a predictor of adverse short term outcome in patients with hepatic dysfunction admitted in MICU.

METHODS:

It was a prospective observational study, conducted from December 2017 to December 2018 in a tertiary care hospital. Two hundred and two patients admitted to the MICU with LFTs as per the inclusion criteria were analyzed and their short-term outcome at 7 days was studied in relation to various parameters.

RESULTS:

LFT abnormalities were present in 202/1126 (17.9%) of the patients admitted to MICU. Critical illness associated liver dysfunction was found in 172 (85.2%) patients, chronic liver disease in 11 (5.4%) patients and acute viral hepatitis in 19 (9.4%) patients. Most common symptom was fever (68.3%) followed by vomiting (48.0%). Among LFT abnormalities, elevated transaminases, raised international normalized ratio and high MELD score on admission correlated with poor short-term outcome. Requirement for inotropes and mechanical ventilation correlated with poor short-term outcome. Mortality did not differ significantly between patients with chronic liver disease, patients with acute viral hepatitis and patients with critical illness associated hepatic dysfunction. Hepatic dysfunction in MICU was associated with poor outcome and a high short-term mortality of 56.4% (114/202).

CONCLUSION:

Liver function abnormality is common in patients who are admitted to the MICU and its presence is an indicator of poor short-term outcome.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença Hepática Terminal / Hepatite Viral Humana Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença Hepática Terminal / Hepatite Viral Humana Idioma: En Ano de publicação: 2022 Tipo de documento: Article